Abstract:Background Ambroxol is a widely used mucoactive drug in sputum clearance of respiratory diseases taken orally and by injection. However, there is a paucity of evidence for inhaled ambroxol in sputum clearance. Methods This study performed a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial at 19 centers in China. Hospitalized adult patients with mucopurulent sputum and expectoration difficulty were recruited. Patients were randomized by 1:1 to receive inhalation of either ambroxol hydrochloride solution 3 mL (22.5 mg) + 0.9% sodium chloride 3 mL or 0.9% sodium chloride 6 mL twice daily for 5 days, with an interval of more than 6 h. The primary efficacy endpoint was the absolute change in the sputum property score after treatment compared to the baseline in the intention-to-treat population. Results Between 10 April 2018 and 23 November 2020, 316 patients were recruited and assessed for eligibility, of whom 138 who received inhaled ambroxol and 134 who received a placebo were included. Patients who received inhaled ambroxol had a significantly greater decrease in the sputum property score compared with patients who received inhalation of placebo (difference: −0.29; 95% CI: −0.53 to −0.05; p = 0.0215). Compared with the placebo, inhaled ambroxol also significantly reduced more expectoration volume in 24 h (difference: −0.18; 95% CI: −0.34 to −0.03; p = 0.0166). There was no significant difference in the proportion of adverse events between the two groups, and no deaths were reported. Discussion In hospitalized adult patients with mucopurulent sputum and expectoration difficulty, inhaled ambroxol was safe and effective for sputum clearance compared with a placebo. Clinical trial registration [ https://www.chictr.org.cn/showproj.html?proj=184677 ], Chinese Clinical Trial Registry [ChiCTR2200066348].

Population Pharmacokinetics of Ambroxol Hydrochloride in Chinese Healthy Male Subjects

Pharmacokinetics and Bioequivalance of Ambroxol Dispersible Tablets in Healthy Volunteers

Pharmacokinetic And Bioequivalence Study Of Three Oral Formulations Of Ambroxol 30 Mg: A Randomized, Three-Period Crossover Comparison In Healthy Volunteers

Clinical effect of large dose of ambroxol in treatment of acute episode of chronic bronchitis (AECB)

Study on Bioequivalence of Ambroxol Hydrochloride Tablets from Domestic and Import

Establish the Population Pharmacokinetics Model of Azithromycin in Chinese Healthy Volunteers

Population Pharmacokinetics of Omeprazole in Healthy Volunteers of Different Nationalities in China by NONMEM

Population Pharmacokinetics of Zolpidem Tartrate Tablets in Healthy Volunteers of Five Different Nationalities in China

Quantitative Detection of Ambroxol in Human Plasma Using HPLC-APCI-MS/MS: Application to a Pharmacokinetic Study

Population Pharmacokinetics of Doxapram in Five Different Chinese Ethnic Groups

Population Pharmacokinetics Of Blonanserin In Chinese Healthy Volunteers And The Effect Of The Food Intake

Population pharmacokinetics of cefixime in Chinese healthy male subjects

Population pharmacokinetics of citalopram by NONMEM

Simultaneous determination of amoxicillin and ambroxol in human plasma by LC-MS/MS: validation and application to pharmacokinetic study

Population Pharmacokinetics of Lithium Carbonate in Young Male Healthy Chinese Volunteers.

Rapid and sensitive liquid chromatography tandem mass spectrometry method for the quantification of ambroxol in human plasma.

Pharmacokinetics of Moxifloxacin Hydrochloride Tablets in Healthy Volunteers

Pharmacokinetic Properties and Bioequivalence of Orally Inhaled Salbutamol in Healthy Chinese Volunteers.

In-depth evaluation of stability and in vivo pharmacokinetics of Ambroxol Hydrochloride Injections

Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension

Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty